Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 98420X103 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (2) | ||||
| Vanguard Group Inc 13G/A | 4.8% |
1/31/2025
Event 12/31/2024
|
||
| Orbimed Advisors LLC 13G/A | 1.7% |
8/14/2025
Event 6/30/2025
|
||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q2 | 1 | 3.23 M | $15.1 M |
| 2026 Q1 | 2 | 3.47 M | $14.3 M |
| 2025 Q4 | 3 | 3.51 M | $14.0 M |
| 2025 Q3 | 2 | 2.51 M | $8.57 M |
| 2025 Q2 | 2 | 653 k | $1.24 M |
| 2025 Q1 | 98 | 98.6 M | $23.6 M |
| 2024 Q4 | 98 | 107 M | $78.6 M |
| 2024 Q3 | 104 | 101 M | $67.3 M |
| 2024 Q2 | 110 | 105 M | $60.9 M |
| 2024 Q1 | 108 | 106 M | $147 M |
| 2023 Q4 | 105 | 104 M | $87.1 M |
| 2023 Q3 | 99 | 112 M | $123 M |
| 2023 Q2 | 106 | 113 M | $219 M |
| 2023 Q1 | 66 | 61.5 M | $53.7 M |
| 2022 Q4 | 63 | 60.8 M | $60.4 M |
| 2022 Q3 | 67 | 43.3 M | $74.0 M |
| 2022 Q2 | 55 | 17.2 M | $16.6 M |
| 2022 Q1 | 64 | 17.5 M | $30.7 M |
| 2021 Q4 | 63 | 17.7 M | $40.4 M |
| 2021 Q3 | 56 | 16.2 M | $85.7 M |
| 2021 Q2 | 68 | 17.2 M | $111 M |
| 2021 Q1 | 65 | 16.2 M | $139 M |
| 2020 Q4 | 55 | 10.5 M | $67.4 M |
| 2020 Q3 | 54 | 10.2 M | $69.3 M |
| 2020 Q2 | 60 | 11.6 M | $106 M |
| 2020 Q1 | 54 | 11.8 M | $118 M |
| 2019 Q4 | 57 | 11.2 M | $120 M |
| 2019 Q3 | 52 | 7.74 M | $98.4 M |
| 2019 Q2 | 47 | 7.62 M | $114 M |
| 2019 Q1 | 31 | 1.79 M | $31.1 M |